Hematology/oncology and stem cell therapy
An open-access journal from King Faisal Specialist Hospital and Research Centre in Riyadh covering blood disorders, cancer and stem cell transplantation, with no author fees. Read by haematologists and transplant physicians, particularly in the Middle East.
Overview
Hematology/Oncology and Stem Cell Therapy is published by Wolters Kluwer Medknow for King Faisal Specialist Hospital and Research Centre (KFSHRC), which DOAJ lists as the journal's institution. DOAJ records it as open access since 2008 under a CC BY-NC-SA licence, with no article processing charge and double anonymous peer review; its keywords are haematology, oncology, stem cells, haematopoietic and solid tumours. The publisher page names Dr Mahmoud Aljurf as Editor-in-Chief and lists continuous publication. The NLM Catalog records a start in 2008 in Riyadh with the King Faisal Cancer Center, a move to Wolters Kluwer Medknow in 2024, quarterly issues and MEDLINE indexing.
Pages like this
not linked directly; found by shared links- ProductDorocubicel (UM171-expanded cord blood)
Shares Allogeneic stem cell transplantation, Acute myeloid leukaemia.
- ProductTreosulfan
Shares Allogeneic stem cell transplantation, Acute myeloid leukaemia.
- TargetCD7
Shares Allogeneic stem cell transplantation, Acute myeloid leukaemia.
- PersonJohn F. DiPersio
Shares Allogeneic stem cell transplantation, Acute myeloid leukaemia.
- ProductBelumosudil
Shares Allogeneic stem cell transplantation, Acute myeloid leukaemia.
- IdeaMRD-guided transplant decisions in intermediate-risk AML
Shares Allogeneic stem cell transplantation, Acute myeloid leukaemia.
- JournalBlood cancer discovery
- JournalJournal of hematology & oncology